2m 2m 2m 2m 2m 2m 2m
OMNIAB (OABI)
NASDAQ
$2.52-$0.10 (-3.85%)
Price as of Jun 03, 2026 5:16 PM EDT- $391.4MMarket Cap
- 91.24%1-Year Change
- BiotechnologyIndustry
OMNIAB (OABI)
$2.52-$0.10 (-3.85%)
OABI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.62 | ||
Change | +$0.01 (+0.38%) | ||
Open | $2.57 | ||
High | $2.74 | ||
Low | $2.55 | ||
Previous Close | $2.61 | ||
Volume | 757,349 | ||
30-Day Average Volume | 1,025,634 | ||
1-Week Change | 2.75% | ||
1-Month Change | 87.14% | ||
1-Year Change | 91.24% | ||
3-Year Change | -39.77% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 145.0M | ||
Total Assets | $293.6M | ||
Market Cap | $391.4M | ||
Enterprise Value | $362.4M | ||
Period: QTR TTM FY | |||
Revenue | $12.0M | ||
Net Income | -$7.7M | ||
Free Cash Flow | -$5.1M | ||
EBIT | -$7.3M | ||
EBITDA | -$1.2M | ||
Net Working Capital | N/A | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -293 | ||
Enterprise Value/Revenue | 30 | ||
P/B | 1 | ||
P/E | -45 | ||
PEG | -1 | ||
Price/Free Cash Flow | -77 | ||
Price/Operating Cash Flow | -80 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue